-transparent.png){kind=logo}
The incidence of tardive dyskinesia under neuroleptic treatment is diversely estimated. The effectiveness of anticholinergics in its prevention is under discussion. Among 52 patients treated with neuroleptics for more than 5 years (mean: 9 years) only 2 developed tardive dyskinesia, and the disorder was transient in each case. The low doses of neuroleptic drugs administered and their systematic association with anticholinergics seem to be partly responsible for this low incidence of tardive dyskinesia.
Related Publications
F Fanget, and
E Henry, and
G Aimard
May 1996,
The American journal of psychiatry,
F Fanget, and
E Henry, and
G Aimard
January 1987,
Acta psychiatrica Belgica,
F Fanget, and
E Henry, and
G Aimard
November 2005,
The Annals of pharmacotherapy,
F Fanget, and
E Henry, and
G Aimard
July 1977,
Journal of neurology,
F Fanget, and
E Henry, and
G Aimard
September 1981,
Arizona medicine,
F Fanget, and
E Henry, and
G Aimard
January 1982,
Advances in neurology,
F Fanget, and
E Henry, and
G Aimard
April 1978,
Annales medico-psychologiques,
F Fanget, and
E Henry, and
G Aimard
January 1988,
Acta psychiatrica Belgica,
F Fanget, and
E Henry, and
G Aimard
January 1980,
Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie = Archives suisses de neurologie, neurochirurgie et de psychiatrie,
F Fanget, and
E Henry, and
G Aimard
January 1986,
Psychopharmacology bulletin,
